{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:11:50Z","timestamp":1792444310250,"version":"4.5.0"},"reference-count":15,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2021,5,1]]},"DOI":"10.1001\/jamadermatol.2021.0596","type":"journal-article","created":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T19:47:27Z","timestamp":1617824847000},"page":"583","source":"Crossref","is-referenced-by-count":67,"title":["Efficacy and Safety of Topical Timolol for the Treatment of Infantile Hemangioma in the Early Proliferative Stage"],"prefix":"10.1001","volume":"157","author":[{"given":"Fania Z.","family":"Mu\u00f1oz-Garza","sequence":"first","affiliation":[{"name":"Dermatology Service, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"R\u00edos","sequence":"additional","affiliation":[{"name":"Dermatology Service, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Ro\u00e9-Crespo","sequence":"additional","affiliation":[{"name":"Dermatology Service, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Bernabeu-Wittel","sequence":"additional","affiliation":[{"name":"Hospital Universitario Virgen del Roc\u00edo, Seville, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Teresa","family":"Montserrat-Garc\u00eda","sequence":"additional","affiliation":[{"name":"Hospital Universitario Virgen del Roc\u00edo, Seville, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu\u00eds","family":"Puig","sequence":"additional","affiliation":[{"name":"Dermatology Service, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignasi","family":"Gich","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology, CIM-Caiber-IIb Sant Pau, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eulalia","family":"Baselga","sequence":"additional","affiliation":[{"name":"Dermatology Service, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain"},{"name":"Nowwith Dermatology Service, Hospital Sant Joan de D\u00e9u, Esplugues de Llobregat, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"4","key":"dbr210004r1","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1111\/bjd.2014.170.issue-4","article-title":"Prospective study of infantile haemangiomas: incidence, clinical characteristics and association with placental anomalies.","volume":"170","author":"Munden","year":"2014","journal-title":"Br J Dermatol"},{"issue":"2","key":"dbr210004r2","doi-asserted-by":"publisher","first-page":"e314","DOI":"10.1542\/peds.2011-3683","article-title":"Early growth of infantile hemangiomas: what parents\u2019 photographs tell us.","volume":"130","author":"Tollefson","year":"2012","journal-title":"Pediatrics"},{"issue":"2","key":"dbr210004r3","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1542\/peds.2007-2767","article-title":"Growth characteristics of infantile hemangiomas: implications for management.","volume":"122","author":"Chang","year":"2008","journal-title":"Pediatrics"},{"issue":"10089","key":"dbr210004r4","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0140-6736(16)00645-0","article-title":"Infantile haemangioma.","volume":"390","author":"L\u00e9aut\u00e9-Labr\u00e8ze","year":"2017","journal-title":"Lancet"},{"issue":"4","key":"dbr210004r5","doi-asserted-by":"publisher","first-page":"e1060","DOI":"10.1542\/peds.2015-2485","article-title":"Diagnosis and management of infantile hemangioma.","volume":"136","author":"Darrow","year":"2015","journal-title":"Pediatrics"},{"issue":"11","key":"dbr210004r6","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1001\/jamadermatol.2016.2905","article-title":"Risk factors for degree and type of sequelae after involution of untreated hemangiomas of infancy.","volume":"152","author":"Baselga","year":"2016","journal-title":"JAMA Dermatol"},{"issue":"10","key":"dbr210004r7","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.2340\/00015555-2681","article-title":"The role of topical timolol in the treatment of infantile hemangiomas: a systematic review and meta-analysis.","volume":"97","author":"Khan","year":"2017","journal-title":"Acta Derm Venereol"},{"issue":"6","key":"dbr210004r8","doi-asserted-by":"publisher","first-page":"e1739","DOI":"10.1542\/peds.2012-3828","article-title":"RCT of timolol maleate gel for superficial infantile hemangiomas in 5- to 24-week-olds.","volume":"131","author":"Chan","year":"2013","journal-title":"Pediatrics"},{"issue":"2","key":"dbr210004r9","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/pde.2006.23.issue-2","article-title":"How to measure a growing hemangioma and assess response to therapy.","volume":"23","author":"Tsang","year":"2006","journal-title":"Pediatr Dermatol"},{"issue":"3","key":"dbr210004r10","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-0355","article-title":"Topical timolol maleate treatment of infantile hemangiomas.","volume":"138","author":"P\u00fcttgen","year":"2016","journal-title":"Pediatrics"},{"issue":"8","key":"dbr210004r11","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1056\/NEJMoa1404710","article-title":"A randomized, controlled trial of oral propranolol in infantile hemangioma.","volume":"372","author":"L\u00e9aut\u00e9-Labr\u00e8ze","year":"2015","journal-title":"N Engl J Med"},{"issue":"2","key":"dbr210004r12","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/pde.12767","article-title":"Topical timolol for infantile hemangiomas: evidence for efficacy and degree of systemic absorption.","volume":"33","author":"Weibel","year":"2016","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"dbr210004r13","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1111\/bjd.2018.178.issue-1","article-title":"Safety and efficacy of topical timolol treatment of infantile haemangioma: a prospective trial.","volume":"178","author":"Borok","year":"2018","journal-title":"Br J Dermatol"},{"issue":"3","key":"dbr210004r14","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.jaad.2019.02.029","article-title":"Systemic timolol exposure following topical application to infantile hemangiomas.","volume":"82","author":"Drolet","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"dbr210004r15","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/pde.2016.33.issue-4","article-title":"Adverse events in young and preterm infants receiving topical timolol for infantile hemangioma.","volume":"33","author":"Frommelt","year":"2016","journal-title":"Pediatr Dermatol"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2778172\/jamadermatology_muozgarza_2021_br_210004_1620146125.7397.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T15:59:15Z","timestamp":1621439955000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2778172"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2021,5,1]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2021.0596","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5,1]]}}}